Amniotic tissue transplantation as a trial of treatment in some lysosomal storage diseases

J Inherit Metab Dis. 1985;8(3):101-4. doi: 10.1007/BF01819289.

Abstract

This communication reports the clinical and biochemical results in six patients: four with mucopolysaccharidosis, one with GM1 gangliosidosis (Morquio B) and one with I-cell disease, who were treated by amniotic tissue transplantation. The sole evident clinical result was the diminishing of corneal clouding in three cases. A slight increase of beta-galactosidase activity in one patient's plasma was observed. The time of improvement was about 2 months after the transplantation and was transitory.

MeSH terms

  • Amnion / transplantation*
  • Child
  • Child, Preschool
  • Female
  • G(M1) Ganglioside / metabolism
  • Gangliosidoses / therapy*
  • Humans
  • Male
  • Mucolipidoses / therapy*
  • Mucopolysaccharidoses / therapy*
  • Mucopolysaccharidosis I / therapy
  • Mucopolysaccharidosis VI / therapy

Substances

  • G(M1) Ganglioside